Guardant Health, Inc. - Common Stock (NQ:GH)

155.68 -6.31 (-3.90%)

Streaming Delayed Price Updated: 9:33 AM EDT, Aug 3, 2026 Add to My Watchlist

Price and Volume

Volume	90,683
Open	158.00
Bid (Size)	154.38 (200)
Ask (Size)	156.98 (200)
Prev. Close	161.99
Today's Range	155.05 - 158.46
52wk Range	41.19 - 176.58
Shares Outstanding	101,298,669
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Cash-Burning Stocks to Target This Week and 1 We Find Risky

Today 0:34 EDT

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sh...

Via StockStory

Guardant Health Q2 Earnings Call Highlights ↗

July 31, 2026

Guardant Health (NASDAQ:GH) reported second-quarter 2026 revenue of $335 million, up 44% from a year earlier, as growth accelerated across its oncology, biopharma and data, and screening businesses....

Via MarketBeat

Performance

YTD	+53.0%	+53.0%
1 Month	-7.8%	-7.8%
3 Month	+70.8%	+70.8%
6 Month	+35.5%	+35.5%
1 Year	+252.3%	+252.3%

More News

Guardant Health (NASDAQ:GH) Shares Surge After Q2 Revenue Beat and Raised 2026 Outlook ↗

July 30, 2026

Via Chartmill

Guardant Health (NASDAQ:GH) Delivers Strong Q2 CY2026 Numbers, Stock Soars

July 30, 2026

Via StockStory

Guardant Health Inc. (NASDAQ:GH) Shines as a Top Minervini Trend Template and High Growth Momentum Pick ↗

June 15, 2026

Via Chartmill

Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

July 30, 2026

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in Upcoming Investor Conferences

July 29, 2026

From Guardant Health, Inc.

Via Business Wire

Guardant Health (GH) Q2 Earnings Report Preview: What To Look For

July 28, 2026

Via StockStory

Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer

July 28, 2026

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Second Quarter 2026 Financial Results on July 30, 2026

July 09, 2026

From Guardant Health, Inc.

Via Business Wire

UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening

July 01, 2026

From Guardant Health, Inc.

Via Business Wire

3 Mid-Cap Stocks We’re Skeptical Of

July 01, 2026

Via StockStory

Why Are Guardant Health (GH) Shares Soaring Today

June 26, 2026

Via StockStory

Why Are Guardant Health (GH) Shares Soaring Today

June 24, 2026

Via StockStory

3 Russell 2000 Stocks We Approach with Caution

June 22, 2026

Via StockStory

Guardant Health Announces FDA Approval of Guardant360 CDx as Companion Diagnostic for Boehringer Ingelheim’s HERNEXEOS®

June 11, 2026

From Guardant Health, Inc.

Via Business Wire

Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗

June 08, 2026

Via The Motley Fool

1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds

June 05, 2026

Via StockStory

June 04, 2026

Via StockStory

3 Unprofitable Stocks Walking a Fine Line

June 01, 2026

Via StockStory

3 Reasons GH is Risky and 1 Stock to Buy Instead

June 01, 2026

Via StockStory

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter ↗

May 31, 2026

Via The Motley Fool

Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All Cylinders

May 28, 2026

Via StockStory

Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting

May 28, 2026

From Guardant Health, Inc.

Via Business Wire

American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines

May 27, 2026

From Guardant Health, Inc.

Via Business Wire

Frequently Asked Questions

Is Guardant Health, Inc. - Common Stock publicly traded?

Yes, Guardant Health, Inc. - Common Stock is publicly traded.

What exchange does Guardant Health, Inc. - Common Stock trade on?

Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Guardant Health, Inc. - Common Stock?

The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market

What is the current price of Guardant Health, Inc. - Common Stock?

The current price of Guardant Health, Inc. - Common Stock is 155.68

When was Guardant Health, Inc. - Common Stock last traded?

The last trade of Guardant Health, Inc. - Common Stock was at 08/03/26 09:33 AM ET

What is the market capitalization of Guardant Health, Inc. - Common Stock?

The market capitalization of Guardant Health, Inc. - Common Stock is 15.77B

How many shares of Guardant Health, Inc. - Common Stock are outstanding?

Guardant Health, Inc. - Common Stock has 16B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.